DSpace university logo mark
詳細検索
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > 110 医歯薬学総合研究科 > 110 学位論文 > 110 学位論文 >

Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa


ファイル 記述 サイズフォーマット
ISYK931_Oshima.pdf689.46 kBAdobe PDF本文ファイル

タイトル: Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa
その他のタイトル: メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討
著者: 大島, 一浩
著者(別表記) : Oshima, Kazuhiro
発行日: 2017年 3月21日
出版者: American Society for Microbiology
引用: Nagasaki University (長崎大学), 博士(医学) (2017-03-21)
抄録: High-dose meropenem (MEPM; 6 g/day) has been approved as a treatment for purulent meningitis; however, little is known regarding its in vivo efficacy in refractory lower respiratory tract infections. The purpose of this study was to evaluate the efficacy of MEPM at 6 g/day in a murine model of severe pneumonia caused by MEPM-resistant Pseudomonas aeruginosa. Experimental pneumonia induced by MEPM-resistant P. aeruginosa was treated with normal-dose MEPM (150 mg/kg of body weight, simulating a 3-g/day regimen in humans) or high-dose MEPM (500 mg/kg, simulating a 6-g/day regimen in humans). Mice treated with high-dose MEPM showed significantly restored survival relative to that of untreated mice and tended to show a survival rate higher than that of mice treated with normal-dose MEPM. The viable bacterial counts (of two clinical isolates) in the lungs decreased significantly in mice treated with high-dose MEPM from those for untreated mice (P < 0.001) or mice treated with normal-dose MEPM (P, <0.01 and <0.05). The number of inflammatory cells in the bronchoalveolar lavage fluid (BALF) was also significantly lower in mice treated with high-dose MEPM than in untreated mice. The free MEPM concentration in the epithelial lining fluid (ELF) exceeded 16 μg/ml for 85 min in mice treated with high-dose MEPM, but not for mice treated with normal-dose MEPM. Our results demonstrate that high-dose MEPM (6 g/day) might provide better protection against pneumonia caused by MEPM-resistant strains of P. aeruginosa than the dose normally administered (less than 3 g/day).
記述: 長崎大学学位論文 学位記番号:博(医歯薬)甲第931号 学位授与年月日:平成29年3月21日 / Author: Kazuhiro Oshima, Shigeki Nakamura, Naoki Iwanaga, Koji Takemoto, Taiga Miyazaki, Kastunori Yanagihara, Yoshitsugu Miyazaki, Hiroshi Mukae, Shigeru Kohno, Koichi Izumikawa / Citation: Antimicrobial Agents and Chemotherapy, 61(1), e02056-16; 2017
キーワード: high dose / meropenem / pharmacokinetics/pharmacodynamics / meropenem-resistant Pseudomonas aeruginosa
URI: http://hdl.handle.net/10069/37694
ISSN: 00664804
DOI: 10.1128/AAC.02056-16
関連リンク : http://hdl.handle.net/10069/37208
権利: © American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 61(1), e02056-16; 2017
資料タイプ: Thesis or Dissertation
原稿種類: ETD
出現コレクション:110 学位論文

引用URI : http://hdl.handle.net/10069/37694

このリポジトリに保管されている文献はすべて著作権により保護されています。
印刷やダウンロード等データの複製は、調査研究・教育または学習を目的とする場合に限定されます。

 

Valid XHTML 1.0! Copyright © 2006-2015 長崎大学附属図書館 - お問い合わせ Powerd by DSpace